Valuation: Accuray Incorporated

Market Cap 27.44M 24.56M 22.9M 20.77M 39.17M 2.62B 39.41M 275M 108M 1.35B 103M 101M 4.36B P/E 2025
-88.5x
P/E 2026 -0.64x
Enterprise Value 171M 153M 142M 129M 244M 16.32B 245M 1.71B 670M 8.42B 641M 627M 27.1B EV / Sales 2025
0.57x
EV / Sales 2026 0.43x
Free-Float
93.34%
Yield 2025 *
-
Yield 2026 -
1 day-4.96%
1 week-27.64%
Current month-19.18%
1 month-11.01%
3 months-19.83%
6 months-48.02%
Current year-73.53%
1 week 0.21
Extreme 0.2112
0.32
1 month 0.21
Extreme 0.2112
0.38
Current year 0.21
Extreme 0.2112
0.93
1 year 0.21
Extreme 0.2112
1.93
3 years 0.21
Extreme 0.2112
3.05
5 years 0.21
Extreme 0.2112
5.93
10 years 0.21
Extreme 0.2112
6.15
Manager TitleAgeSince
Chief Executive Officer 67 2025-10-19
Director of Finance/CFO 46 2022-05-08
Chief Tech/Sci/R&D Officer - 2022-09-13
Director TitleAgeSince
Chairman 68 2020-12-31
Director/Board Member 65 2019-09-05
Director/Board Member 62 2021-08-16
Date Insider Type Main position Quantity % Market Cap. Importance
10/5/26 Free

Director

150,000 0.1256%
9/23/26 Free

Chief Financial Officer

28,726 0.0241%
5/29/26 Free

Executive/Senior Manager

650,000 0.5472%
Change 5-day change 1-year change 3-year change Capi.($)
-4.96%-27.64%-87.60%-92.26% 27.44M
+0.64%-2.15%+26.24%+37.23% 243B
+0.63%-0.00%+7.83%+5.59% 155B
+0.87%+5.21%-1.86%+60.69% 150B
+2.60%+3.40%-53.83%-9.87% 61.93B
+1.38%-0.96%+18.42%+23.56% 49.12B
+1.25%+4.68%-16.06%-17.25% 48.78B
+0.46%+0.02%+23.95%+57.27% 48.08B
-0.09%+4.37%+3.41%+36.99% 47.95B
-0.38%-1.82%+28.48%+72.15% 42.62B
Average -0.21%+0.88%-5.10%+17.41% 84.61B
Weighted average by Cap. +0.25%+2.97%+7.84%+31.10%

Financials

2025 2026
Net sales 459M 410M 383M 347M 655M 43.83B 659M 4.6B 1.8B 22.62B 1.72B 1.68B 72.78B 402M 360M 335M 304M 574M 38.42B 577M 4.03B 1.58B 19.83B 1.51B 1.48B 63.81B
Net income -1.59M -1.42M -1.33M -1.2M -2.27M -152M -2.29M -15.96M -6.25M -78.48M -5.98M -5.84M -253M -49.19M -44.04M -41.05M -37.24M -70.23M -4.7B -70.67M -493M -193M -2.43B -185M -181M -7.81B
Net Debt 119M 106M 99.28M 90.05M 170M 11.37B 171M 1.19B 467M 5.87B 447M 437M 18.88B 143M 128M 120M 108M 205M 13.69B 206M 1.44B 562M 7.07B 538M 526M 22.74B
Projected Income Statement - Annual - Accuray Incorporated
Logo Accuray Incorporated
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Employees
809
Date Price Change Volume
26-10-12 US$0.2183 -4.96% 832,891
26-10-09 US$0.2297 -4.85% 1,729,171
26-10-08 US$0.2414 -4.74% 2,461,731
26-10-07 US$0.2534 -3.10% 1,972,825
26-10-06 US$0.2615 -13.32% 1,844,137

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Accuray Incorporated
  1. Stock Market
  2. Stocks
  3. ARAY Stock